FDA Approved: PARICALCITOL — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original ANDA for paricalcitol from Eugia US LLC, a vitamin D receptor activator, for the treatment of secondary hyperparathyroidism in adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

ORIG AP for PARICALCITOL (PARICALCITOL)